The Pseudokinase Domain of JAK2 Is a Dual-Specificity Protein Kinase That Negatively Regulates Cytokine Signaling

作者: Daniela Ungureanu , Jinhua Wu , Tuija Pekkala , Yashavanthi Niranjan , Clifford Young

DOI: 10.1038/NSMB.2099

关键词:

摘要: Human JAK2 tyrosine kinase mediates signaling through numerous cytokine receptors. The JH2 domain functions as a negative regulator and is presumed to be catalytically inactive pseudokinase, but the mechanism(s) for its inhibition of remains unknown. Mutations in lead increased activity, contributing myeloproliferative neoplasms (MPNs). Here we show that dual-specificity protein phosphorylates two regulatory sites JAK2: Ser523 Tyr570. Inactivation catalytic activity basal downstream signaling. Notably, different MPN mutations abrogated cells, (V617F) patient cells phosphorylation Tyr570 was reduced, suggesting loss contributes pathogenesis MPNs. These results identify previously unrecognized mechanism control JAK2.

参考文章(39)
Kunihiro Yamaoka, Pipsa Saharinen, Marko Pesu, Vance ET Holt, Olli Silvennoinen, John J O'Shea, The Janus kinases (Jaks) Genome Biology. ,vol. 5, pp. 253- 253 ,(2004) , 10.1186/GB-2004-5-12-253
Ke Shuai, Bin Liu, Regulation of JAK–STAT signalling in the immune system Nature Reviews Immunology. ,vol. 3, pp. 900- 911 ,(2003) , 10.1038/NRI1226
O. Silvennoinen, B. A. Witthuhn, F. W. Quelle, J. L. Cleveland, T. Yi, J. N. Ihle, Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 90, pp. 8429- 8433 ,(1993) , 10.1073/PNAS.90.18.8429
N. Jura, Y. Shan, X. Cao, D. E. Shaw, J. Kuriyan, Structural analysis of the catalytically inactive kinase domain of the human EGF receptor 3 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 106, pp. 21608- 21613 ,(2009) , 10.1073/PNAS.0912101106
Robert Kralovics, Francesco Passamonti, Andreas S. Buser, Soon-Siong Teo, Ralph Tiedt, Jakob R. Passweg, Andre Tichelli, Mario Cazzola, Radek C. Skoda, A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders The New England Journal of Medicine. ,vol. 352, pp. 1779- 1790 ,(2005) , 10.1056/NEJMOA051113
Titus J. Boggon, Yiqun Li, Paul W. Manley, Michael J. Eck, Crystal structure of the Jak3 kinase domain in complex with a staurosporine analog Blood. ,vol. 106, pp. 996- 1002 ,(2005) , 10.1182/BLOOD-2005-02-0707
Jérôme Boudeau, Diego Miranda-Saavedra, Geoffrey J. Barton, Dario R. Alessi, Emerging roles of pseudokinases Trends in Cell Biology. ,vol. 16, pp. 443- 452 ,(2006) , 10.1016/J.TCB.2006.07.003
Andrej Shevchenko, Henrik Tomas, Jan Havli, Jesper V Olsen, Matthias Mann, None, In-gel digestion for mass spectrometric characterization of proteins and proteomes Nature Protocols. ,vol. 1, pp. 2856- 2860 ,(2006) , 10.1038/NPROT.2006.468
Edward P. Feener, Felicia Rosario, Sarah L. Dunn, Zlatina Stancheva, Martin G. Myers, Tyrosine Phosphorylation of Jak2 in the JH2 Domain Inhibits Cytokine Signaling Molecular and Cellular Biology. ,vol. 24, pp. 4968- 4978 ,(2004) , 10.1128/MCB.24.11.4968-4978.2004
Douglas A Harrison, The JAK-STAT Pathway Molecular Immunology. ,vol. 37, pp. 1- 11 ,(2000) , 10.1016/S0161-5890(00)00018-3